Kenny Kevin J. 4
4 · Orthofix Medical Inc. · Filed Jan 10, 2024
Insider Transaction Report
Form 4
Kenny Kevin J
President of Global Spine
Transactions
- Tax Payment
Common Stock
2024-01-08$13.29/sh−1,511$20,081→ 145,810 total - Exercise/Conversion
Performance Share Units
2024-01-08−5,959→ 0 totalExercise: $0.00→ Common Stock (5,959 underlying) - Exercise/Conversion
Common Stock
2024-01-08+5,959→ 147,321 total
Footnotes (2)
- [F1]On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.
- [F2]Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).